Frankfurt - Delayed Quote EUR
Shanghai Junshi Biosciences Co., Ltd. (8SJ.F)
1.6400
+0.0400
+(2.50%)
At close: May 16 at 9:59:01 AM GMT+2
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
1,948,317
1,948,317
1,502,550
1,453,493
4,024,841
Cost of Revenue
498,861
498,861
667,290
526,282
1,258,187
Gross Profit
1,449,456
1,449,456
835,260
927,211
2,766,654
Operating Expense
2,749,658
2,749,658
3,287,276
3,643,474
3,359,361
Operating Income
-1,300,202
-1,300,202
-2,452,016
-2,716,263
-592,707
Net Non Operating Interest Income Expense
-7,722
-7,722
70,420
31,648
9,146
Pretax Income
-1,359,028
-1,359,028
-2,489,887
-2,675,202
-592,648
Tax Provision
22,552
22,552
43,995
-93,107
135,533
Net Income Common Stockholders
-1,282,398
-1,282,398
-2,281,624
-2,386,067
-718,557
Diluted NI Available to Com Stockholders
-1,282,398
-1,282,398
-2,281,624
-2,386,067
-718,557
Basic EPS
-1.97
-1.30
-2.32
-2.60
-0.80
Diluted EPS
-1.97
-1.30
-2.32
-2.60
-0.80
Basic Average Shares
985,177.9920
984,908.4470
985,302.1660
917,465.1660
892,659.6890
Diluted Average Shares
985,177.9920
984,908.4470
985,302.1660
917,465.1660
892,659.6890
Total Expenses
3,248,519
3,248,519
3,954,566
4,169,756
4,617,548
Net Income from Continuing & Discontinued Operation
-1,282,398
-1,282,398
-2,281,624
-2,386,067
-718,557
Normalized Income
-1,280,109
-1,280,109
-2,274,649
-2,411,199.7458
-804,444
Interest Income
43,630
43,630
99,426
61,018
30,979
Interest Expense
51,352
51,352
29,006
29,370
21,833
Net Interest Income
-7,722
-7,722
70,420
31,648
9,146
EBIT
-1,307,676
-1,307,676
-2,460,881
-2,645,832
-570,815
EBITDA
-1,023,801
-1,023,801
-2,157,661
-2,352,178
-308,256
Reconciled Cost of Revenue
498,861
498,861
667,290
526,282
1,258,187
Reconciled Depreciation
283,875
283,875
303,220
293,654
262,559
Net Income from Continuing Operation Net Minority Interest
-1,282,398
-1,282,398
-2,281,624
-2,386,067
-718,557
Total Unusual Items Excluding Goodwill
-3,052
-3,052
-9,300
26,039
114,516
Total Unusual Items
-3,052
-3,052
-9,300
26,039
114,516
Normalized EBITDA
-1,020,749
-1,020,749
-2,148,361
-2,378,217
-422,772
Tax Rate for Calcs
0.0003
0.0003
0.0003
0
0.0003
Tax Effect of Unusual Items
-763
-763
-2,325
906.2542
28,629
12/31/2021 - 6/24/2022
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade